不妊治療クリニックにおける生殖補助医療(ART)の世界市場2017-2021

Technavioが発行した調査報告書(IRTNTR15936)
◆英語タイトル:Global Assisted Reproductive Technology Market in Fertility Clinics 2017-2021
◆商品コード:IRTNTR15936
◆発行会社(リサーチ会社):Technavio
◆発行日:2017年11月13日
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

Technavio社が発行した当調査レポートでは、不妊治療クリニックにおける生殖補助医療(ART)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、不妊治療クリニックにおける生殖補助医療(ART)の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。Technavio社は不妊治療クリニックにおける生殖補助医療(ART)の世界市場が2017-2021年期間中に年平均4.36%成長すると予測しています。当レポート上に記載されている主な企業は、CooperSurgical、EMD Serono、Ferring Pharmaceuticals、Irvine Scientific、Vitrolife等です。

・エグゼクティブサマリー
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:市場概観
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:業界の構造分析
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:市場規模及び予測
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:地域別分析
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:成長要因
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:課題
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:市場動向
・不妊治療クリニックにおける生殖補助医療(ART)の世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

About Assisted Reproductive Technology in Fertility Clinics
Infertility is a medical condition that affects both men and women. Generally, a couple is considered infertile when they are unable to conceive after a 12-month period of unprotected sexual intercourse. ART consists of a wide range of procedures that are used to treat infertility in men and women. These procedures are rendered to patients primarily in clinics, which treat infertility and are collectively referred to as fertility clinics.

Technavio’s analysts forecast the global assisted reproductive technology market in fertility clinics to grow at a CAGR of 4.36% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global assisted reproductive technology market in fertility clinics for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of ART solutions specifically to fertility clinics.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Assisted Reproductive Technology Market in Fertility Clinics 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• CooperSurgical
• EMD Serono
• Ferring Pharmaceuticals
• Irvine Scientific
• Vitrolife

[Other prominent vendors]
• Anecova
• Cook Medical
• CRITEX
• Esco Micro
• Genea
• IHMedical
• IKS International
• INVO Bioscience
• IVFtech
• Kitazato
• Pantec Biosolutions
• Smiths Medical

[Market driver]
• Growing awareness about ART procedures
• For a full, detailed list, view our report

[Market challenge]
• Limited insurance coverage and improper regulatory oversight
• For a full, detailed list, view our report

[Market trend]
• Emergence of digital innovations
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: MARKET LANDSCAPE
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: MARKET SEGMENTATION BY PATIENT TYPE
• Segmentation by patient type
• Comparison by patient type
• Global ART market in fertility clinics by female infertility treatment
• Global ART market in fertility clinics by male infertility treatment
• Market opportunity by patient type

PART 07: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• ART market in fertility clinics in EMEA
• ART market in fertility clinics in Americas
• ART market in fertility clinics in APAC
• Market opportunity

PART 08: DECISION FRAMEWORK

PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 10: MARKET TRENDS
• Emergence of digital innovations
• Growing acceptance of same-sex marriages
• Emergence of IVF mega clinics

PART 11: VENDOR LANDSCAPE
• Competitive scenario

PART 12: VENDOR ANALYSIS
• Vendor overview
• CooperSurgical
• EMD Serono
• Ferring Pharmaceuticals
• Irvine Scientific
• Vitrolife
• Other prominent vendors

PART 13: APPENDIX
• List of abbreviations

[List of Exhibits] Exhibit 01: Stages of infertility treatment
Exhibit 02: Top IVF clinics around the world
Exhibit 03: Global ART market in fertility clinics 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global ART market in fertility clinics by patient type 2016-2021 (%)
Exhibit 06: Comparison by patient type
Exhibit 07: Global ART market in fertility clinics by female infertility treatment 2016-2021 ($ millions)
Exhibit 08: Global ART market in fertility clinics by female infertility treatment: Year-over-year growth 2017-2021 (%)
Exhibit 09: Global ART market in fertility clinics by male infertility treatment 2016-2021 ($ millions)
Exhibit 10: Global ART market in fertility clinics by male infertility treatment: Year-over-year growth 2017-2021 (%)
Exhibit 11: Global ART market in fertility clinics by geography 2016-2021 (%)
Exhibit 12: Regional comparison
Exhibit 13: ART market in fertility clinics in EMEA 2016-2021 ($ billions)
Exhibit 14: ART market in fertility clinics in EMEA: Year-over-year growth 2017-2021 (%)
Exhibit 15: Top 3 countries in EMEA
Exhibit 16: ART market in fertility clinics in Americas 2016-2021 ($ billions)
Exhibit 17: ART market in fertility clinics in Americas: Year-over-year growth 2017-2021 (%)
Exhibit 18: Top 3 countries in Americas
Exhibit 19: ART market in fertility clinics in APAC 2016-2021 ($ billions)
Exhibit 20: ART market in fertility clinics in APAC: Year-over-year growth 2017-2021 (%)
Exhibit 21: Top 3 countries in APAC
Exhibit 22: Types of infertility in males and females
Exhibit 23: Global average fertility rate 2010-2015 (births per woman)
Exhibit 24: Global average birth rate 2010-2015 (per 1,000 people)
Exhibit 25: State-wise obesity prevalence in US
Exhibit 26: Obesity prevalence across Europe as percentage of population 2014
Exhibit 27: ART success rate in the US 2002-2014
Exhibit 28: Percentage of geriatric population in Europe 2014-2016
Exhibit 29: Cost breakdown of IVF by various stages in US
Exhibit 30: Top mobile applications improving infertility awareness
Exhibit 31: Same-sex couples in Canada 2001-2016 (%)
Exhibit 32: Global ART market in fertility clinics: Competitive parameters
Exhibit 33: Strategic success factors of consideration for companies
Exhibit 34: CooperSurgical: Profile
Exhibit 35: CooperSurgical: Strength analysis
Exhibit 36: CooperSurgical: Strategy assessment
Exhibit 37: CooperSurgical: Opportunity assessment
Exhibit 38: EMD Serono: Profile
Exhibit 39: EMD Serono: Strength analysis
Exhibit 40: EMD Serono: Strategy assessment
Exhibit 41: EMD Serono: Opportunity assessment
Exhibit 42: Ferring Pharmaceuticals: Profile
Exhibit 43: Ferring Pharmaceuticals: Strength analysis
Exhibit 44: Ferring Pharmaceuticals: Strategy assessment
Exhibit 45: Ferring Pharmaceuticals: Opportunity assessment
Exhibit 46: Irvine Scientific: Profile
Exhibit 47: Irvine Scientific: Strength analysis
Exhibit 48: Irvine Scientific: Strategy assessment
Exhibit 49: Irvine Scientific: Opportunity assessment
Exhibit 50: Vitrolife: Profile
Exhibit 51: Vitrolife: Strength analysis
Exhibit 52: Vitrolife: Strategy assessment
Exhibit 53: Vitrolife: Opportunity assessment



【掲載企業】

CooperSurgical, EMD Serono, Ferring Pharmaceuticals, Irvine Scientific, Vitrolife, Anecova, Cook Medical, CRITEX, Esco Micro, Genea, IHMedical, IKS International, INVO Bioscience, IVFtech, Kitazato, Pantec Biosolutions, and Smiths Medical.


【レポートのキーワード】

不妊治療クリニック、生殖補助医療(ART)、不妊治療法

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 不妊治療クリニックにおける生殖補助医療(ART)の世界市場2017-2021(Global Assisted Reproductive Technology Market in Fertility Clinics 2017-2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆